BSA-625
BSA-625 is a broad-spectrum antibiotic combination containing Amoxycillin 500 mg and Potassium Clavulanate 125 mg, used for the effective treatment of a wide range of bacterial infections. This combination works by killing bacteria and preventing them from developing resistance.
Amoxycillin inhibits bacterial cell wall synthesis, while Clavulanate enhances its effectiveness by blocking beta-lactamase enzymes produced by resistant bacteria. BSA-625 is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, dental infections, and ENT infections.
Key Benefits
- Broad-spectrum antibiotic coverage
- Effective against beta-lactamase producing bacteria
- Helps treat respiratory, urinary, skin, dental & ENT infections
- Improves treatment success in resistant bacterial infections
- Trusted 500 mg + 125 mg strength
Composition
Each film-coated tablet contains:
- Amoxycillin Trihydrate IP
(equivalent to Amoxycillin) – 500 mg - Potassium Clavulanate IP
(equivalent to Clavulanic Acid) – 125 mg - Excipients – q.s.
- Colour: Titanium Dioxide IP
Dosage
- As directed by the physician
Storage Instructions
- Store in a cool and dry place below 25°C
- Protect from direct light and moisture
- Keep out of reach of children
Pack Size
- 1 × 10 Tablets
Safety Information
- Schedule H Prescription Drug
- Not to be sold by retail without the prescription of a Registered Medical Practitioner
- To be used only under medical supervision
Manufacturer & Marketer
- Manufactured by: Soft Touch Pharmaceuticals India Ltd.
(WHO-GMP & GLP Certified Company) - Marketed by: AVEO India Healthcare Pvt. Ltd.